Articles by Disease (Renal Cell Carcinoma)

Estrogen-Induced Genetic Alterations and Their Role in Carcinogenicity

Journal: Current Genomics
Volume: 5
Page: 245-257
Author(s): D. Roy and K. P. Singh

Introduction: P2 Receptors

Journal: Current Topics in Medicinal Chemistry
Volume: 4
Page: 793-803
Author(s): Geoffrey Burnstock

Prostaglandin J2 Family and the Cardiovascular System

Journal: Current Vascular Pharmacology
Volume: 2
Page: 103-114
Author(s): Toshiyuki Sasaguri and Yoshikazu Miwa

Mining for Protein Kinase Substrates: Integration of Biochemistry, Genetics and Proteomics

Journal: Current Proteomics
Volume: 1
Page: 83-102
Author(s): Benjamin K. Benton, Christian Rommel, Mark Velleca and Christian Pasquali

The Protein Profile of Fibroblasts: The Role of Proteomics

Journal: Current Proteomics
Volume: 1
Page: 167-178
Author(s): Daniela Quaglino, Federica Boraldi, Luca Bini and Nicola Volpi

Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 11
Page: 731-745
Author(s): T. L. Underiner, B. Ruggeri and D. E. Gingrich

Articles by Disease (Renal Cell Carcinoma)

Estrogen-Induced Genetic Alterations and Their Role in Carcinogenicity

Introduction: P2 Receptors

Prostaglandin J2 Family and the Cardiovascular System

Mining for Protein Kinase Substrates: Integration of Biochemistry, Genetics and Proteomics

The Protein Profile of Fibroblasts: The Role of Proteomics

Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

Current Status of Delivery Systems to Improve Target Efficacy of Oligonu-cleotides

Anti-Gene Strategies to Down-Regulate Gene Expression in Mammalian Cells

Cancer Prevention and Therapy in a Preclinical Mouse Model: Impact of FHIT Viruses

The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery